Meloxicam and diclofenac do not change VEGF and PDGF-ABserum levels of platelet-rich plasma | Zendy

Burkay Utku | Zendy; Gürhan Dönmez | Zendy; Gülriz Erişgen | Zendy; Şenay Akın | Zendy; Haydar A. Demirel | Zendy; Feza Korkusuz | Zendy; Mahmut Nedim Doral | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Meloxicam and diclofenac do not change VEGF and PDGF-ABserum levels of platelet-rich plasma

Author(s) -

Burkay Utku,

Gürhan Dönmez,

Gülriz Erişgen,

Şenay Akın,

Haydar A. Demirel,

Feza Korkusuz,

Mahmut Nedim Doral

Publication year - 2017

Publication title -

turkish journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 27

eISSN - 1303-6165

pISSN - 1300-0144

DOI - 10.3906/sag-1602-60

Subject(s) - medicine , meloxicam , diclofenac , vegf receptors , platelet derived growth factor receptor , platelet rich plasma , pharmacology , platelet , plasma levels , growth factor , receptor

Platelet-rich plasma (PRP) application has gained widespread interest for musculoskeletal injuries. Nonsteroidal antiinflammatory drugs are frequently used in sports medicine before and/or after PRP application. Our study seeks to determine whether serum levels of platelet-derived growth factor-AB (PDGF-AB) and vascular endothelial growth factor (VEGF) levels of PRP would be affected by nonsteroidal antiinflammatory drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research